{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:13Z","timestamp":1786997593102,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.toxicon.2023.107209","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:00:10Z","timestamp":1688814010000},"page":"107209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Botulinum toxin in the management of parkinsonian disorders"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3126-8002","authenticated-orcid":false,"given":"Talyta","family":"Grippe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-8629","authenticated-orcid":false,"given":"Robert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5334\/tohm.712","article-title":"Tremor in Parkinson's disease: from pathophysiology to advanced therapies","volume":"12","author":"Abusrair","year":"2022","journal-title":"Tremor and Other Hyperkinetic Mov."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107209_bib2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1572-0241.2003.07514.x","article-title":"Treatment of outlet obstruction constipation in Parkinson\u2019s disease with botulinum neurotoxin A","volume":"98","author":"Albanese","year":"2003","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/toxins13010042","article-title":"Botulinum toxin in movement disorders: an update","volume":"13","author":"Anandan","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107209_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxicon.2015.06.004","article-title":"Treatment of camptocormia with botulinum toxin","volume":"107","author":"Bertram","year":"2015","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.toxicon.2023.107209_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.otot.2008.10.008","article-title":"The use of botulinum toxin in patients with sialorrhea","volume":"19","author":"Bhayani","year":"2008","journal-title":"Operat. Tech. Otolaryngol. Head Neck Surg."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107209_bib6","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/WNL.48.6.1491","article-title":"Apraxia of lid opening: a review","volume":"48","author":"Boghen","year":"1997","journal-title":"Neurol."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/cjn.2017.245","article-title":"Botulinum toxin type A for pain in advanced Parkinson's disease","volume":"45","author":"Bruno","year":"2018","journal-title":"Can. J. Neurol. Sci.\/J. Can. Sci. Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/cjn.2016.279","article-title":"Botulinum toxin use in refractory pain and other symptoms in parkinsonism","volume":"43","author":"Bruno","year":"2016","journal-title":"Can. J. Neurol. Sci.\/J. Can. Sci. Neurol."},{"key":"10.1016\/j.toxicon.2023.107209_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.toxicon.2017.08.018","article-title":"Botulinum toxin in parkinsonism: the when, how, and which for botulinum toxin injections","volume":"147","author":"Cardoso","year":"2018","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.23929","article-title":"Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial","volume":"27","author":"Chinnapongse","year":"2012","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/toxins13010058","article-title":"Botulinum toxin: an update on pharmacology and newer products in development","volume":"13","author":"Choudhury","year":"2021","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.1186","article-title":"Treatment of dystonic clenched fist with botulinum toxin: treatment of Dystonic Clenched Fist with BTXA","volume":"16","author":"Cordivari","year":"2001","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus \u2018blind\u2019 intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107209_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JPD-140379","article-title":"Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin","volume":"4","author":"Egevad","year":"2014","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.23522","article-title":"Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio: letter to the Editor","volume":"26","author":"Espay","year":"2011","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.toxicon.2023.107209_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/toxins12100626","article-title":"Management of anterocapitis and anterocollis: a novel ultrasound guided approach combined with electromyography for botulinum toxin injection of longus colli and longus capitis","volume":"12","author":"Farrell","year":"2020","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.toxicon.2023.107209_bib17","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.toxicon.2023.107209_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004150170134","article-title":"The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study","volume":"248","author":"Giladi","year":"2001","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease: botulinum Toxin A and B for Sialorrhea","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107209_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/16501977-2094","article-title":"Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: a case series and a pilot study","volume":"48","author":"Gupta","year":"2016","journal-title":"J. Rehabil. Med."},{"issue":"9","key":"10.1016\/j.toxicon.2023.107209_bib21","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.WNL.0000027361.73814.0E","article-title":"Blepharospasm: recent advances","volume":"59","author":"Hallett","year":"2002","journal-title":"Neurol."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/cjn.2021.42","article-title":"Effects of onabotulinum toxin A on gait in Parkinson's disease patients with foot dystonia","volume":"49","author":"Huang","year":"2022","journal-title":"Can. J. Neurol. Sci.\/J. Can. Sci. Neurol."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107209_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000104713","article-title":"Botulinum toxin injection into Riolan's muscle: somatosensory \u2018trick.\u2019","volume":"58","author":"Inoue","year":"2007","journal-title":"Eur. Neurol."},{"issue":"11","key":"10.1016\/j.toxicon.2023.107209_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/toxins12110691","article-title":"Sialorrhea in Parkinson's disease","volume":"12","author":"Isaacson","year":"2020","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.toxicon.2023.107209_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: state of the art: botulinum toxin","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2023.107209_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2017.09.003","article-title":"An update on new and unique uses of botulinum toxin in movement disorders","volume":"147","author":"Jankovic","year":"2018","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40120-019-00155-6","article-title":"Therapy of sialorrhea with botulinum neurotoxin","volume":"8","author":"Jost","year":"2019","journal-title":"Neurol.Ther."},{"issue":"17","key":"10.1016\/j.toxicon.2023.107209_bib28","first-page":"e1982","article-title":"SIAXI: placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea","volume":"92","author":"Jost","year":"2019","journal-title":"Neurol."},{"issue":"8","key":"10.1016\/j.toxicon.2023.107209_bib29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.parkreldis.2007.01.007","article-title":"Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections","volume":"13","author":"Kalf","year":"2007","journal-title":"Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.toxicon.2023.107209_bib30","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00415-009-5098-2","article-title":"Prevalence and definition of drooling in Parkinson's disease: a systematic review","volume":"256","author":"Kalf","year":"2009","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.toxicon.2023.107209_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114733","article-title":"A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment","volume":"9","author":"Kleiner-Fisman","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.toxicon.2023.107209_bib32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mds.870090605","article-title":"Apraxia of lid opening: a focal eyelid dystonia: clinical study of 32 patients","volume":"9","author":"Krack","year":"1994","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.toxicon.2023.107209_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107209_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling","volume":"256","author":"Lagalla","year":"2009","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107209_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mds.870100425","article-title":"Botulinum a toxin for the so-called apraxia of lid opening","volume":"10","author":"Lepore","year":"1995","journal-title":"Mov. Disord."},{"issue":"Supplment","key":"10.1016\/j.toxicon.2023.107209_bib37","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00002508-200211001-00005","article-title":"Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction","volume":"18","author":"Lew","year":"2002","journal-title":"Clin. J. Pain"},{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000117409","article-title":"Treatment of dystonia occurring in parkinsonian syndromes by botulinum toxin","volume":"37","author":"Limousin","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.toxicon.2023.107209_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2021.05.024","article-title":"Botulinum toxin treatment of dystonic anterocollis: what to inject","volume":"88","author":"Marion","year":"2021","journal-title":"Park. Relat. Disord."},{"issue":"0","key":"10.1016\/j.toxicon.2023.107209_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5334\/tohm.186","article-title":"Comparable botulinum toxin outcomes between primary and secondary blepharospasm: a retrospective analysis","volume":"4","author":"Martinez-Ramirez","year":"2014","journal-title":"Tremor and Other Hyperkinetic Mov."},{"key":"10.1016\/j.toxicon.2023.107209_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson's disease: prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107209_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s42399-018-0005-8","article-title":"The management of urine storage dysfunction in the neurological patient","volume":"1","author":"Mehnert","year":"2019","journal-title":"SN Compr. Clin. Med."},{"issue":"9","key":"10.1016\/j.toxicon.2023.107209_bib43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.mayocp.2017.06.010","article-title":"Botulinum toxin in Parkinson disease tremor","volume":"92","author":"Mittal","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107209_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/00016357.2010.545035","article-title":"Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms","volume":"69","author":"M\u00f8ller","year":"2011","journal-title":"Acta Odontol. Scand."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clineuro.2008.12.007","article-title":"Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients?","volume":"111","author":"N\u00f3brega","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1\u20132","key":"10.1016\/j.toxicon.2023.107209_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2006.11.015","article-title":"Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?","volume":"253","author":"N\u00f3brega","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107209_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurol."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107209_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870100317","article-title":"\u201cOff\u201d painful dystonia in Parkinson's disease treated with botulinum toxin","volume":"10","author":"Pacchetti","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2023.107209_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"54","author":"Pal","year":"2000","journal-title":"Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S031716710001489X","article-title":"Effectiveness of BoNT A in Parkinson's disease upper limb tremor management","volume":"40","author":"Rahimi","year":"2013","journal-title":"Can. J. Neurol. Sci.\/J. Can. Sci. Neurol."},{"issue":"0","key":"10.1016\/j.toxicon.2023.107209_bib52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5334\/tohm.240","article-title":"Effective management of upper limb parkinsonian tremor by IncobotulinumtoxinA injections using sensor-based biomechanical patterns","volume":"5","author":"Rahimi","year":"2015","journal-title":"Tremor and Other Hyperkinetic Mov."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107209_bib53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000341621","article-title":"Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor","volume":"68","author":"Rana","year":"2012","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.toxicon.2023.107209_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.10.009","article-title":"Incobotulinum toxin A in Parkinson's disease with foot dystonia: a double blind randomized trial","volume":"46","author":"Rieu","year":"2018","journal-title":"Park. Relat. Disord."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107209_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178670","article-title":"Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections","volume":"12","author":"Samotus","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2023.107209_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420954083","article-title":"Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis","volume":"13","author":"Samotus","year":"2020","journal-title":"Ther. Advances in Neurol. Disord."},{"issue":"10","key":"10.1016\/j.toxicon.2023.107209_bib57","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/mds.21019","article-title":"Botulinum toxin a may be efficacious as treatment for jaw tremor in Parkinson's disease","volume":"21","author":"Schneider","year":"2006","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease\u2014an evidence\u2010based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2023.107209_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.05.001","article-title":"Dystonia and Parkinson's disease: what is the relationship?","volume":"132","author":"Shetty","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.toxicon.2023.107209_bib60","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40265-013-0068-5","article-title":"Efficacy and safety of botulinum toxin A intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic review","volume":"73","author":"Soljanik","year":"2013","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.toxicon.2023.107209_bib61","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson's disease: a review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.toxicon.2023.107209_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2017.08.020","article-title":"Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease","volume":"44","author":"Triadafilopoulos","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"19","key":"10.1016\/j.toxicon.2023.107209_bib63","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.0b013e318219fab3","article-title":"Behavioral therapy to treat urinary incontinence in Parkinson disease","volume":"76","author":"Vaughan","year":"2011","journal-title":"Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107209_bib64","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/01.wnl.0000172930.63669.c8","article-title":"Botulinum toxin injections do not improve freezing of gait in Parkinson disease","volume":"65","author":"Wieler","year":"2005","journal-title":"Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107209_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3988\/jcn.2005.1.2.159","article-title":"Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism","volume":"1","author":"Yoon","year":"2005","journal-title":"J. Clin. Neurol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:24:31Z","timestamp":1758576271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010123001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":65,"alternative-id":["S0041010123001952"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107209","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin in the management of parkinsonian disorders","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107209"}}